White label ELPA - ClinicalTrials.eu

Study of bone marrow mesenchymal cells with biomaterial to treat delayed or non-healing long bone fractures using ORTHOALLO-BM-MSC and MBCP+ in adult patients

Recruiting

3 1 1
Investigated drugs:
- ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS, FROM SELECTED DONORS
Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
- Hormone receptor positive breast cancer
Investigated drugs:
+1
Study of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment

Recruiting

2 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Study of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1

Recruiting

3 1 1
Investigated diseases:
- Myotonic dystrophy
Investigated drugs:
- Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
Study of ranolazine in patients with ST-elevation heart attack and multiple blocked coronary arteries to improve small blood vessel function

Recruiting

2 1 1 1
Investigated diseases:
- Acute myocardial infarction
Investigated drugs:
- Ranolazine
Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Recruiting

3 1 1 1
Investigated drugs:
+6
Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

Recruiting

2 1
Investigated diseases:
- Cardiac failure
Study of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer

Recruiting

2 1 1
Investigated drugs:
Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Recruiting

3 1 1
Investigated diseases:
- Migraine
Investigated drugs:
- Rimegepant
Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies